- Report
- May 2025
- 350 Pages
Global
From €3510EUR$3,995USD£3,028GBP
- Report
- May 2025
- 350 Pages
Global
From €3510EUR$3,995USD£3,028GBP
- Report
- June 2025
- 381 Pages
Global
From €2600EUR$3,170USD£2,321GBP
- Report
- March 2025
- 150 Pages
Global
From €2636EUR$3,000USD£2,274GBP
- Report
- May 2025
- 183 Pages
Global
From €3115EUR$3,545USD£2,687GBP
€3461EUR$3,939USD£2,986GBP
- Report
- May 2025
- 197 Pages
Global
From €3115EUR$3,545USD£2,687GBP
€3461EUR$3,939USD£2,986GBP
- Report
- July 2025
- 462 Pages
Global
From €5140EUR$5,850USD£4,434GBP
- Report
- July 2025
- 381 Pages
Global
From €5140EUR$5,850USD£4,434GBP
- Report
- April 2022
- 400 Pages
Global
€1538EUR$1,750USD£1,326GBP
- Report
- October 2021
- 433 Pages
Global
From €2250EUR$2,743USD£2,009GBP
- Report
- July 2021
- 259 Pages
Global
From €2150EUR$2,621USD£1,920GBP
- Report
- May 2024
- 200 Pages
Global
From €3646EUR$4,150USD£3,145GBP
- Report
- January 2024
- 106 Pages
Global
€4389EUR$4,995USD£3,786GBP
The Antibody Technology market is a subset of the larger Biotechnology industry. It focuses on the development and production of antibodies, which are proteins used to identify and neutralize foreign substances in the body. Antibodies are used in a variety of medical treatments, including cancer, autoimmune diseases, and infectious diseases. They are also used in research and diagnostics.
The Antibody Technology market is highly competitive, with many companies offering a range of products and services. Companies in the market specialize in the production of antibodies, antibody engineering, antibody discovery, and antibody-based therapeutics. They also provide services such as antibody production, antibody engineering, and antibody-based diagnostics.
Some of the major companies in the Antibody Technology market include AbbVie, Amgen, AstraZeneca, Biogen, Bristol-Myers Squibb, Eli Lilly, Genentech, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more
